http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2580630-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a58192f499cb0f0169fc1900a7672f44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf18c0bf3154463a6ae0a822b279463b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
filingDate | 2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce03e6ff5481238a0f782337a5a78d91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4745c9836df620501859283454fcd5fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3d6a49a23c60b619e0a4c1b715fdc20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27582d9e1a27d8fcfbe137dfe4b9e257 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a6c2d03f77b012d3e5be2a490f4ce3 |
publicationDate | 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2580630-C1 |
titleOfInvention | Antibacterial drug in form of drops for treating eye diseases in animals |
abstract | FIELD: veterinary science. n SUBSTANCE: invention relates to ophthalmology, and aims at treating eyes of agricultural and domestic animals, as well as fur animals in livestock farms, personal farms, nurseries, veterinary clinics and stations to combat diseases of animals. Therapeutic agent is made in the form of drops and comprises azithromycin, netilmicin, nafazolin, benzalkonium chloride, mannitol, sodium chloride, sodium or potassium dihydrophosphate, sodium or potassium hydrophosphate and water for injections in declared amount. n EFFECT: drug preparation shows high efficacy in treating wide range of eye diseases of animals, harmless, has no allergenic action and almost has no contraindications in use. n 2 cl, 2 tbl, 10 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112545985-A |
priorityDate | 2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.